CAR T-Cell Therapy: Expert Guidance for Community Practice

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC with Pharmacotherapy Credit

Credits:

1.00
Evolving CLL Treatment Recommendations

Content Format:

Text Module

Credit Type:

ACPE | AMA | ANCC

Credits:

0.75
Key Studies in Gastrointestinal Cancers: Independent Conference Coverage of the ESMO World Congress on Gastrointestinal Cancer 2022

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.00
Expert Think Tank: Lung Cancer Experts Discuss Current Standard of Care and Ongoing Challenges in the Care of Patients With EGFR-Mutated NSCLC

Content Format:

Text Module

Credit Type:

ACPE | AMA | ANCC

Credits:

1.25
Key Studies in Hematologic Malignancies: Independent Conference Coverage of the 2022 ASCO Annual Meeting

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.50
Evolution in Expert Recommendations for CLL Treatment

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Indolent B-Cell Lymphomas: Clinical Application of New Advances in Community Practice

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00
Measurable Residual Disease Assessment in Chronic Lymphocytic Leukemia

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Patient Knowledge Gaps, Concerns, and Misperceptions About CLL

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Patient Knowledge Gaps, Concerns, and Misperceptions About CLL

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
A Discussion With Experts on the Evolving Therapeutic Landscape in T-Cell Lymphomas: Focus on EZH1/2 Inhibitors

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.50
Biomarkers in Gastrointestinal Cancer: Applying the Latest Data in Community Practice

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00
CLL-Related Symptoms and Managing Adverse Events With BTK Inhibitors

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Managing Adverse Events With BCL-2 and PI3K Inhibitors in CLL

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25